Enliven Therapeutics, Inc.
ELVN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001672619
In the last 90 days, Enliven Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 214 institutions reported holding it in 13F filings for Q2 2026, worth $4.06B in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Enliven Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- −3 vs. Q3 2021
- Shares held
- 14.9M
- −376.0K (−2.5%) vs. Q3 2021
- Total value
- $33.6M
- −$28.9M (−46.2%) vs. Q3 2021
- New holders
- 5
- 12 more added
- Sold out
- 8
- 9 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ELVN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 214 | $4.06B |
| Q1 2026 | 171 | $2.43B |
| Q4 2025 | 126 | $960.9M |
| Q3 2025 | 134 | $1.22B |
| Q2 2025 | 125 | $1.19B |
| Q1 2025 | 122 | $983.9M |
| Q4 2024 | 114 | $1.12B |
| Q3 2024 | 102 | $1.22B |
| Q2 2024 | 93 | $1.13B |
| Q1 2024 | 74 | $780.8M |
| Q4 2023 | 62 | $539.8M |
| Q3 2023 | 61 | $533.8M |
| Q2 2023 | 63 | $797.9M |
| Q1 2023 | 45 | $735.0M |
| Q4 2022 | 36 | $74.7M |
| Q3 2022 | 31 | $18.8M |
| Q2 2022 | 26 | $13.1M |
| Q1 2022 | 31 | $26.2M |
| Q4 2021 | 35 | $33.6M |
| Q3 2021 | 38 | $62.5M |
| Q2 2021 | 31 | $86.3M |
| Q1 2021 | 40 | $92.9M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Enliven Therapeutics, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 78 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 32 | $0 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 298 | $0 | 0.00% | +298 | New |
| Federated Hermes, Inc. | 2,776 | $6.00K | 0.00% | +1,100+65.6% | Added |
| UBS Group AG | 4,485 | $10.0K | 0.00% | +4,485 | New |
| Tower Research Capital LLC (TRC) | 4,850 | $11.0K | 0.00% | +2,734+129.2% | Added |
| Acadian Asset Management LLC | 8,592 | $19.0K | 0.00% | +8,592 | New |
| Bank of America Corp | 9,478 | $21.0K | 0.00% | +119+1.3% | Added |
| Northern Trust Corp | 15,314 | $34.0K | 0.00% | 00.0% | Unchanged |
| Occudo Quantitative Strategies LP | 18,253 | $41.0K | 0.00% | −169−0.9% | Reduced |
| Bank of New York Mellon Corp | 18,661 | $42.0K | 0.00% | 00.0% | Unchanged |
| Prelude Capital Management, LLC | 18,844 | $42.0K | 0.00% | +18,844 | New |
| State Street Corp | 21,198 | $48.0K | 0.00% | 00.0% | Unchanged |
| Great Valley Advisor Group, Inc. | 22,611 | $51.0K | 0.00% | −4,800−17.5% | Reduced |
| Susquehanna International Group, LLP | 36,792 | $83.0K | 0.00% | +25,443+224.2% | Added |
| Tudor Investment Corp Et Al | 51,923 | $117.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 54,777 | $123.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 71,850 | $162.0K | 0.00% | −31,953−30.8% | Reduced |
| Walleye Capital LLC | 77,180 | $174.0K | 0.01% | −90,477−54.0% | Reduced |
| D. E. Shaw & Co., Inc. | 83,866 | $189.0K | 0.00% | +21,875+35.3% | Added |
| BlackRock Inc. | 103,795 | $234.0K | 0.00% | +700+0.7% | Added |
| Bridgeway Capital Management, LLC | 125,200 | $282.0K | 0.01% | 00.0% | Unchanged |
| Pura Vida Investments, LLC | 195,535 | $440.0K | 0.05% | +195,535 | New |
| Two Sigma Advisers, LP | 257,800 | $580.0K | 0.00% | −2,800−1.1% | Reduced |
| Two Sigma Investments, LP | 262,205 | $590.0K | 0.00% | +12,710+5.1% | Added |
| Laurion Capital Management LP | 264,681 | $596.0K | 0.01% | −35,319−11.8% | Reduced |
| Woodline Partners LP | 290,436 | $653.0K | 0.01% | +156,272+116.5% | Added |
| Morgan Stanley | 330,781 | $744.0K | 0.00% | +40,133+13.8% | Added |
| Renaissance Technologies LLC | 439,600 | $989.0K | 0.00% | +165,300+60.3% | Added |
| Vanguard Group Inc | 483,904 | $1.09M | 0.00% | −1,000−0.2% | Reduced |
| Rock Springs Capital Management LP | 842,302 | $1.90M | 0.04% | +13,200+1.6% | Added |
| Goldman Sachs Group Inc | 843,748 | $1.90M | 0.00% | +805,786+2,122.6% | Added |
| FMR LLC | 2,010,154 | $4.52M | 0.00% | −300,536−13.0% | Reduced |
| NEA Management Company, LLC | 3,586,371 | $8.07M | 0.16% | −430,799−10.7% | Reduced |
| OrbiMed Advisors LLC | 4,386,568 | $9.87M | 0.13% | 00.0% | Unchanged |
| Lion Point Capital, LP | 0 | $0 | 0.00% | −833,333−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −43,233−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −23,199−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −19,646−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −11,983−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −11,680−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −8,148−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −100−100.0% | Sold out |